P. vivax Control and Elimination: Can We Achieve It Without Radical Cure?

October 15, 2026 by PATH

As countries work to control and eliminate Plasmodium vivax, questions remain about the role of radical cure in reducing transmission and sustaining progress toward elimination. While elimination may be a long-term goal for some countries, others must prioritize controlling disease burden and transmission. Is radical cure essential to achieving these objectives, or can countries make meaningful progress through other approaches? How should policymakers and malaria programs weigh the opportunities and challenges of deploying 8-aminoquinolines at scale? This session will explore the epidemiological evidence behind P. vivax persistence, the role of radical cure in control and elimination strategies, and the implications for countries pursuing different malaria goals.

What we'll cover

  • Policy and programmatic considerations for countries pursuing different goals
  • The role of 8-aminoquinolines in national malaria control and elimination strategies
  • The contribution of radical cure to reducing disease burden and transmission
  • The role of relapse reservoirs in sustaining transmission
  • Epidemiological considerations for P. vivax control and elimination

Speakers to be confirmed.

GSK logo with text

Join the conversation

View all past and upcoming PATH Live Forums

PATH Live Forums are curated live conversations with experts from PATH and our partners, with plenty of time for your questions.

Explore the Forums